Organon (OGN) Research & Development (2020 - 2026)

Organon (OGN) has reported Research & Development for 7 consecutive years, with $93.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development fell 3.12% year-over-year to $93.0 million; the TTM figure through Mar 2026 stood at $363.0 million (down 15.97% YoY), while the FY2025 annual figure was $366.0 million, down 21.96% from the prior year.
• Research & Development came in at $93.0 million for Q1 2026 at Organon, up from $91.0 million in the prior quarter.
• The five-year high for Research & Development was $170.0 million in Q1 2024, with the low at $27.0 million in Q2 2022.
• Average Research & Development over 5 years is $110.9 million, with a median of $116.0 million recorded in 2024.
• Across the five-year window, Research & Development slumped 64.47% in 2022 and jumped 374.07% in 2023, its largest moves.
• Year by year, Research & Development stood at $142.0 million in 2022, then retreated by 5.63% to $134.0 million in 2023, then decreased by 2.99% to $130.0 million in 2024, then dropped by 30.0% to $91.0 million in 2025, then advanced by 2.2% to $93.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $93.0 million, $91.0 million, and $84.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.